[1] Jeon YK,Kim MR,Huh JE,et al.Cystatin C as an early biomarker of nephropathy in patients with type 2 diabetes[J].J Korean Med Sci,2011,26(2):258-263.[2] Isiklar OO,Barutcuoglu B,Kabaroglu C, et al.Do cardiac risk factors affect the homocysteine and asymmetric dimethylarginine relationship in patients with coronary artery diseases?[J].Clin Biochem,2012,45(16/17):1325-1330.[3] Banecka-Majkutewicz Z,Sawuáa W,Kadziński L,et al.Homocysteine,heat shock proteins,genistein and vitamins in ischemic stroke-pathogenic and therapeutic implications[J].Acta Biochimica Polonica,2012,59(4):495-499.[4] Filler G,Bokenkamp A,Hofmann W,et al.Cys C as a marker of GFR-history,indications,and future researc[J].Clin Biochem,2005,38 (1):1-8.[5] Pavkov ME,Knowler WC,Hanson RL,et al.Comparison of serum cystatin C,serum creatinine,measured GFR,and estimated GFR to assess the risk ofkidney failure in American Indians with diabetic nephropathy[J].Am J Kidney Dis,2013,62(1):33-41.[6] Suliman ME,Stenvinkel P,Heimburger O,et al.Plasma sulfur aminoacids in relation to cardiovascular disease,nutritionalstatus,and diabetes melittus in patients with chonic renal failure at start of dialysis therapy [J].Am J Kidney Dis,2002,40(3):480-488.[7] Davies L,Wilmshurst EG,McElduff A,et al.The relationship among homocysteine,creatinine clearance,and albuminuria in patients with type 2 diabetes[J].Diabetes Care,2001,24(10):1805-1809.[8] Huang T,Asimi S,Lou D,et al.Plasma phospholipid polyunsaturated fatty acids and homocysteine in Chinese type 2 diabetes patients[J].Asia Pac J Clin Nutr,2012,21(3):394-399.[9] Hiltunen MO,Yla-Herttuala S.DNA methylation,smooth muscle cells,and atherigenesis[J].Arteioscler Thromb Vase Biol,2003,23(10):1750-1753.[10] Aso Y,Yoshida N,Okumum K,et al.Coagulation and inflammation in overt diabetic nephropathy:association with hyperhomo-cysteinemia [J].Clin Chim Acta,2004,348(12):139-145.[11] Becker A,Henry RM,Kostense PJ,et al.Plasma homocysteine and Sadenosylmethionine in erythrocytes as determinants of carotid intimamedia thickness different effects in diabetic and non-diabetic individuals [J].Atherosclerosis,2003,169(2):323-330.[12] Bukhari SA,Naqvi SA,Nagra SA,et al.Assessing of oxidative stress related parameters in diabetes mellitus type 2:cause excessive damaging to DNA and enhanced homocysteine in diabetic patients[J].Pak J Pharm Sci,2015,28(2):483-491.[13] Dandana A,Gammoudi I,Chalghoum A,et al.Clinical utility of serum cystatin C in predicting coronary artery disease in patients without chronic kidney disease[J].J Clin Lab Anal,2014,28(3):191-197.[14] 陈振宇,文艺,张少华,等.胃转流术对2型糖尿病大鼠肾脏的保护作用及其机制探讨[J].解放军医学杂志,2014,39(6):454-458. |